Treatment with 4-phenylbutyrate prevents pancreatic amyloid formation in obese mice overexpressing human islet amyloid polypeptide

被引：0
|
作者：
de Pablo, S. [1 ,2 ]
Montane, J. [1 ,2 ]
Castano, C. [1 ,2 ]
Rodriguez-Comas, J. [1 ,2 ]
Alcarraz-Vizan, G. [1 ,2 ]
Servitja, J. -M. [1 ,2 ]
Novials, A. [1 ,2 ]
机构：
[1] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain
[2] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
602
引用
收藏
页码：S273 / S274
页数：2
相关论文
共 50 条
  • [41] Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation
    Harroun, TA
    Bradshaw, JP
    Ashley, RH
    FEBS LETTERS, 2001, 507 (02) : 200 - 204
  • [42] Nucleobindin 1 Caps Human Islet Amyloid Polypeptide Protofibrils to Prevent Amyloid Fibril Formation
    Gupta, Ruchi
    Kapoor, Neeraj
    Raleigh, Daniel P.
    Sakmar, Thomas P.
    JOURNAL OF MOLECULAR BIOLOGY, 2012, 421 (2-3) : 378 - 389
  • [43] Biologically active human islet amyloid polypeptide/amylin in transgenic mice
    vanHulst, KL
    Born, W
    Muff, R
    Oosterwijk, C
    Blankenstein, MA
    Lips, CJM
    Fischer, JA
    Hoppener, JWM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (01) : 107 - 113
  • [44] CHRONIC OVERPRODUCTION OF ISLET AMYLOID POLYPEPTIDE AMYLIN IN TRANSGENIC MICE - IYSOSOMAL LOCALIZATION OF HUMAN ISLET AMYLOID POLYPEPTIDE AND LACK OF MARKED HYPERGLYCEMIA OR HYPERINSULINEMIA
    HOPPENER, JWM
    VERBEEK, JS
    DEKONING, EJP
    OOSTERWIJK, C
    VANHULST, KL
    VISSERVERNOOY, HJ
    HOFHUIS, FMA
    VANGAALEN, S
    BERENDS, MJH
    HACKENG, WHL
    JANSZ, HS
    MORRIS, JF
    CLARK, A
    CAPEL, PJA
    LIPS, CJM
    DIABETOLOGIA, 1993, 36 (12) : 1258 - 1265
  • [45] Evidence for islet amyloid fibril formation in a new mouse model of insulinoma producing and secreting human islet amyloid polypeptide
    Andrikopoulos, S
    Verchere, CB
    Howell, WM
    Wight, TN
    Kahn, SE
    DIABETES, 1998, 47 : A197 - A197
  • [46] Hexapeptide inhibitors of islet amyloid polypeptide aggregation prevent islet amyloid formation and enhance survival of cultured human islets
    Marzban, L
    Scrocchi, LA
    Warnock, GL
    Rosenberg, L
    Fraser, PE
    Verchere, CB
    DIABETES, 2005, 54 : A391 - A391
  • [47] Islet olligomerization in transgenic mice over-expressing human islet amyloid polypeptide
    Hai-Luzhao, Lanhe
    Sui, Yi
    Kong, Ebenezer K. C.
    Lai, Fernand M. M.
    Tong, Peter C. Y.
    Chan, Juliana C. N.
    DIABETES, 2008, 57 : A463 - A463
  • [48] Culture of human islets is associated with impaired processing of pro-islet amyloid polypeptide and rapid islet amyloid formation
    Marzban, L
    Trigo, G
    Soukhatcheva, G
    Verchere, CB
    DIABETES, 2005, 54 : A391 - A391
  • [49] Bisphenol analogues differently affect human islet polypeptide amyloid formation
    Huang, Lizi
    Liao, Mingyan
    Yang, Xin
    Gong, Hao
    Ma, Liang
    Zhao, Yudan
    Huang, Kun
    RSC ADVANCES, 2016, 6 (09): : 7239 - 7248
  • [50] Rosiglitazone Treatment Does Not Decrease Amyloid Deposition in Transplanted Islets From Transgenic Mice Expressing Human Islet Amyloid Polypeptide
    Udayasankar, J.
    Zraika, S.
    Aston-Mourney, K.
    Subramanian, S. L.
    Brooks-Worrell, B. M.
    Taborsky, G. J.
    Hull, R. L.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (02) : 574 - 579
12345